- Home
- BOE vs MLAB Comparison
BOE vs MLAB Comparison
Compare BOE & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOE
- MLAB
- Stock Information
- Founded
- BOE 2005
- MLAB 1982
- Country
- BOE United States
- MLAB United States
- Employees
- BOE N/A
- MLAB N/A
- Industry
- BOE Trusts Except Educational Religious and Charitable
- MLAB Industrial Machinery/Components
- Sector
- BOE Finance
- MLAB Industrials
- Exchange
- BOE Nasdaq
- MLAB Nasdaq
- Market Cap
- BOE 634.0M
- MLAB 680.0M
- IPO Year
- BOE N/A
- MLAB N/A
- Fundamental
- Price
- BOE $10.88
- MLAB $123.84
- Analyst Decision
- BOE
- MLAB Hold
- Analyst Count
- BOE 0
- MLAB 2
- Target Price
- BOE N/A
- MLAB $140.00
- AVG Volume (30 Days)
- BOE 166.1K
- MLAB 37.3K
- Earning Date
- BOE 01-01-0001
- MLAB 05-30-2025
- Dividend Yield
- BOE 7.30%
- MLAB 0.52%
- EPS Growth
- BOE N/A
- MLAB N/A
- EPS
- BOE N/A
- MLAB N/A
- Revenue
- BOE N/A
- MLAB $237,747,000.00
- Revenue This Year
- BOE N/A
- MLAB $13.48
- Revenue Next Year
- BOE N/A
- MLAB $4.74
- P/E Ratio
- BOE N/A
- MLAB N/A
- Revenue Growth
- BOE N/A
- MLAB 11.68
- 52 Week Low
- BOE $8.80
- MLAB $83.68
- 52 Week High
- BOE $10.48
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- BOE 56.35
- MLAB 58.56
- Support Level
- BOE $10.76
- MLAB $116.81
- Resistance Level
- BOE $10.78
- MLAB $128.55
- Average True Range (ATR)
- BOE 0.14
- MLAB 4.62
- MACD
- BOE 0.06
- MLAB 1.56
- Stochastic Oscillator
- BOE 87.39
- MLAB 76.09
About BOE Blackrock Enhanced Global Dividend Trust of Beneficial Interest
Blackrock Enhanced Global Dividend Trust has an investment objective to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. Further, it focuses on investing in a portfolio of equity securities and utilizing an option writing to seek total return performance and enhance distributions.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.